David M. Urso

Insider Reports History

Location: San Diego, CA
Signature: /s/ Brian G. Drazba, as attorney in fact
Transaction view: Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by David M. Urso:

Form 4 holding President and CEO, Director

MEI Pharma, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 166,571
Estimated value
Report date: 02 Jun 2023
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by David M. Urso

4 MEIP

MEI Pharma, Inc.

Report period: 02 Jun 2023
Transactions: 1
Transaction value: $0
Filing time: 06 Jun 2023, 16:37
Role: President and CEO, Director
Next action: Open filing details

4 MEIP

MEI Pharma, Inc.

Report period: 05 Jul 2022
Transactions: 1
Transaction value: $0
Filing time: 07 Jul 2022, 16:22
Role: Chief Operating Officer & GC
Next action: Open filing details

4 MEIP

MEI Pharma, Inc.

Report period: 01 Jul 2021
Transactions: 2
Transaction value: -$72,986
Filing time: 06 Jul 2021, 18:49
Role: Chief Operating Officer & GC
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .